Cleopatra Hospital Company is trading 2.9% up at $16.48 today as investors digest a 22% surge in Q1 2026 revenue despite a decline in net profit.
- The company reported a 22% year-on-year increase in consolidated revenues for the first quarter, signaling robust top-line growth and market demand.
- Net profit attributable to the parent fell 41% and EPS declined compared to Q1 2025, highlighting significant margin pressure during the period.
- The stock is rebounding from a recent close of $16.01, suggesting that investors are currently prioritizing long-term expansion potential over short-term bottom-line headwinds.